AstraZeneca (AZN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AstraZeneca

    NASDAQ: AZN · Real-Time Price · USD
    81.70
    -0.08 (-0.10%)
    At close: Sep 05, 2025, 3:59 PM
    81.97
    0.33%
    After-hours: Sep 05, 2025, 07:44 PM EDT

    AstraZeneca Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 8.69B 6.9B 2.5B -265M
    Depreciation & Amortization
    		 5.07B 4.93B 5.48B 6.53B
    Stock-Based Compensation
    		 n/a 579M 619M 615M
    Other Working Capital
    		 862M 969M -184M 444M
    Other Non-Cash Items
    		 -1B -2.37B -1.93B -2.32B
    Deferred Income Tax
    		 n/a n/a -619M -615M
    Change in Working Capital
    		 -893M 300M 3.76B 2.02B
    Operating Cash Flow
    		 11.86B 10.35B 9.81B 5.96B
    Capital Expenditures
    		 -4.59B -3.78B -2.57B -2.2B
    Cash Acquisitions
    		 -3.93B -1.18B -1.06B -9.43B
    Purchase of Investments
    		 -96M -136M -159M -184M
    Sales Maturities Of Investments
    		 108M 129M 42M 105M
    Other Investing Acitivies
    		 -2.14B -1.52B 789M 654M
    Investing Cash Flow
    		 -7.98B -4.06B -2.96B -11.06B
    Debt Repayment
    		 1.81B -965M -1.2B 7.89B
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 -4.63B -4.48B -4.36B -3.86B
    Other Financial Acitivies
    		 -1.13B -1.15B -1.29B -418M
    Financial Cash Flow
    		 -4B -6.57B -6.82B 3.65B
    Net Cash Flow
    		 -208M -346M -55M -1.51B
    Free Cash Flow
    		 7.28B 6.57B 7.24B 3.76B

    Add to Watchlist